Project Name,Region,Country,Site ID,Subject ID,Latest Visit (SV) (Source: Rave EDC: BO4),Subject Status (Source: PRIMARY Form),Input files,,,,,,,,,CPMD,,,,,,,,,,,,,,,,,,,,,,SSM,,,,,
,,,,,,,Missing Visits,Missing Page,# Coded terms,# Uncoded Terms,# Open issues in LNR,# Open Issues reported for 3rd party reconciliation in EDRR,Inactivated forms and folders,# eSAE dashboard review for DM,# eSAE dashboard review for safety,Visit status,Page status (Source: (Rave EDC : BO4)),,,,,Queries status (Source:(Rave EDC : BO4)),,,,,,,,Page Action Status (Source: (Rave EDC : BO4)),,,,,,Protocol Deviations (Source:(Rave EDC : BO4)),,PI Signatures (Source: (Rave EDC : BO4)),,,,,
,,,,,,,,,,,,,,,,# Expected Visits (Rave EDC : BO4),# Pages Entered,# Pages with Non-Conformant data,# Total CRFs with queries & Non-Conformant data,# Total CRFs without queries & Non-Conformant data,% Clean Entered CRF,# DM Queries,# Clinical Queries,# Medical Queries,# Site Queries,# Field Monitor Queries,# Coding Queries,# Safety Queries,#Total Queries,# CRFs Require Verification (SDV),# Forms Verified,# CRFs Frozen,# CRFs Not Frozen,# CRFs Locked,# CRFs Unlocked,# PDs Confirmed,# PDs Proposed,# CRFs Signed,CRFs overdue for signs within 45 days of Data entry,CRFs overdue for signs between 45 to 90 days of Data entry,CRFs overdue for signs beyond 90 days of Data entry,Broken Signatures,CRFs Never Signed
Responsible LF for action,,,,,,,,,,,,,,,,,,Site/CRA,,,,DM,CSE/CDD,CDMD/Medical Lead,Site/CRA,CRA,Coder,Safety Team,,CRA,,,DM,,,CD LF,,Investigator,,,,,
Study 20,ASIA,AUS,Site 47,Subject 190,Screening,Screening,,,,,,,,,,1,7,0,,,,0,0,0,8,0,0,0,8,6,0,0,0,0,0,0,0,0,6,0,0,0,6
Study 20,ASIA,AUS,Site 466,Subject 3544,Cycle 2 Day 15 (1),On Trial,,,,,,,,,,5,64,0,,,,0,4,0,5,3,0,0,12,33,27,0,0,0,0,2,0,0,54,5,0,0,59
Study 20,ASIA,AUS,Site 466,Subject 3545,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,2,0,0,2,0,3,0,0,0,0,0,0,0,6,0,0,0,6
Study 20,EMEA,CZE,Site 8,Subject 15,Screening,Screening,,,,,,,,,,0,1,0,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
Study 20,EMEA,FRA,Site 9,Subject 16,Cycle 1 Day 1 (1),On Trial,,,,,,,,,,2,28,0,,,,0,0,0,2,1,0,0,3,27,0,0,0,0,0,0,0,0,27,0,0,0,27
Study 20,EMEA,FRA,Site 9,Subject 3512,Screening,Screening,,,,,,,,,,1,21,0,,,,0,0,0,1,0,0,0,1,13,0,0,0,0,0,0,0,0,19,0,0,0,19
Study 20,EMEA,ITA,Site 87,Subject 627,Unplanned Visit (3),On Trial,,,,,,,,,,3,59,0,,,,0,3,0,0,0,0,0,3,23,28,0,0,0,0,0,0,0,51,0,0,0,51
Study 20,ASIA,KOR,Site 417,Subject 3227,Screening,Screening,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,0,0,14,0,0,0,14
Study 20,EMEA,NLD,Site 124,Subject 1067,Cycle 1 Day 1 (1),On Trial,,,,,,,,,,2,28,0,,,,0,0,0,0,0,0,0,0,27,0,0,0,0,0,0,0,0,27,0,0,0,27
Study 20,ASIA,SGP,Site 353,Subject 2844,Unplanned Visit (6),On Trial,,,,,,,,,,8,95,0,,,,0,0,0,16,0,0,0,16,60,27,0,0,0,0,0,0,58,22,7,0,7,22
Study 20,ASIA,SGP,Site 353,Subject 2845,Cycle 4 Day 1 (1),On Trial,,,,,,,,,,8,72,0,,,,0,0,0,0,0,0,0,0,25,11,0,0,0,0,0,0,30,16,19,0,2,33
Study 20,ASIA,SGP,Site 353,Subject 3735,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,9,0,0,9
Study 20,ASIA,SGP,Site 353,Subject 3736,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,10,0,0,10
Study 20,ASIA,SGP,Site 353,Subject 3737,Cycle 1 Day 1 (1),On Trial,,,,,,,,,,2,28,0,,,,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,0,0,26,0,0,0,26
Study 20,AMERICA,USA,Site 783,Subject 4903,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,9,0,0,0,0,0
Study 20,AMERICA,USA,Site 783,Subject 4904,Cycle 3 Day 15 (1),On Trial,,,,,,,,,,7,85,0,,,,0,1,0,1,4,0,1,7,21,60,0,0,0,0,0,0,50,26,0,0,6,20
Study 20,AMERICA,USA,Site 784,Subject 4905,Screening,Screening,,,,,,,,,,1,3,0,,,,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,2,0,0,0,2
Study 20,AMERICA,USA,Site 784,Subject 4906,Screening,Screening,,,,,,,,,,1,4,0,,,,0,0,0,1,0,0,0,1,2,0,0,0,0,0,0,0,0,3,0,0,0,3
Study 20,AMERICA,USA,Site 785,Subject 4907,Screening,Screening,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,6,0,0,0,6
Study 20,AMERICA,USA,Site 575,Subject 3947,Screening,Screening,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,3,3,0,0,6
Study 20,AMERICA,USA,Site 575,Subject 3948,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,1,0,0,1,1,4,0,0,0,0,0,0,0,9,0,0,0,9
Study 20,AMERICA,USA,Site 575,Subject 3949,Cycle 1 Day 15 (1),On Trial,,,,,,,,,,3,36,0,,,,0,6,0,1,1,0,0,8,2,15,0,0,0,0,0,0,0,35,0,0,0,35
,,,12,22,Total:,,,,,,,,,,,52,608,0,,,,0,14,0,35,12,0,1,62,284,186,0,0,,,,,147,352,53,0,15,390
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
